Pfizer Singapore and BioNTech SE (Nasdaq: BNTX, "BioNTech") announced that the Health Sciences Authority has approved the companies' LP.8.1-adapted monovalent COVID-19 vaccine (COMIRNATY® LP.8.1; ...